On September 3, 2020 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in three virtual investor conferences including Citi’s 15th Annual BioPharma Conference taking place September 9-10, 2020, the H.C. Wainwright 22nd Annual Global Investment Conference taking place September 14-16, 2020 and the Cantor Global Healthcare Conference taking place September 15-17, 2020 (Press release, CymaBay Therapeutics, SEP 3, 2020, View Source [SID1234564401]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Conference
Date: Wednesday, September 9
Time: 1-on-1 meetings only

H.C. Wainwright 22nd Annual Global Healthcare Conference
Date: Monday, September 14
Time: 1:30 pm Eastern Time
Webcast: View Source

Cantor Global Healthcare Conference
Date: Wednesday, September 16
Time: 10:40 am Eastern Time
Webcast: View Source